# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001610618-24-000041
Filing Date
2024-04-22
Accepted
2024-04-22 16:56:44
Documents
110
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CIDARA THERAPEUTICS, INC. 2023 FORM 10-K | cdtx-20231231.htm iXBRL | 10-K | 3698511
2 | CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION | exhibit322023-12.htm | EX-3.2 | 10689
3 | AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY | exhibit1052023-12.htm | EX-10.5 | 16408
4 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | exhibit2312023-12.htm | EX-23.1 | 3225
5 | CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 | exhibit3112023-12.htm | EX-31.1 | 11487
6 | CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 | exhibit3122023-12.htm | EX-31.2 | 11737
7 | CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 | exhibit3212023-12.htm | EX-32.1 | 7006
8 | CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 | exhibit3222023-12.htm | EX-32.2 | 7297
9 | INCENTIVE COMPENSATION RECOUPMENT POLICY | exhibit9712023-12.htm | EX-97.1 | 45272
15 | GRAPHIC | cdtx-20231231_g1.jpg | GRAPHIC | 23028
16 | GRAPHIC | cdtx-20231231_g10.jpg | GRAPHIC | 131758
17 | GRAPHIC | cdtx-20231231_g11.jpg | GRAPHIC | 110340
18 | GRAPHIC | cdtx-20231231_g12.jpg | GRAPHIC | 47123
19 | GRAPHIC | cdtx-20231231_g13.jpg | GRAPHIC | 581005
20 | GRAPHIC | cdtx-20231231_g14.jpg | GRAPHIC | 634367
21 | GRAPHIC | cdtx-20231231_g15.jpg | GRAPHIC | 637536
22 | GRAPHIC | cdtx-20231231_g2.jpg | GRAPHIC | 265744
23 | GRAPHIC | cdtx-20231231_g3.jpg | GRAPHIC | 40726
24 | GRAPHIC | cdtx-20231231_g4.jpg | GRAPHIC | 33311
25 | GRAPHIC | cdtx-20231231_g5.jpg | GRAPHIC | 78600
26 | GRAPHIC | cdtx-20231231_g6.jpg | GRAPHIC | 60994
27 | GRAPHIC | cdtx-20231231_g7.jpg | GRAPHIC | 49980
28 | GRAPHIC | cdtx-20231231_g8.jpg | GRAPHIC | 80495
29 | GRAPHIC | cdtx-20231231_g9.jpg | GRAPHIC | 42486
| Complete submission text file | 0001610618-24-000041.txt |  | 22617574

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cdtx-20231231.xsd | EX-101.SCH | 61099
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cdtx-20231231_cal.xml | EX-101.CAL | 87767
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cdtx-20231231_def.xml | EX-101.DEF | 422786
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cdtx-20231231_lab.xml | EX-101.LAB | 669112
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cdtx-20231231_pre.xml | EX-101.PRE | 620727
114 | EXTRACTED XBRL INSTANCE DOCUMENT | cdtx-20231231_htm.xml | XML | 3526707

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36912 | Film No.: 24861831
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)